Hirschel B - Search Results

1

Ambrosioni J, Calmy A, Hirschel B. Ambrosioni J, et al. Among authors: hirschel b. J Int AIDS Soc. 2011 May 25;14:28. doi: 10.1186/1758-2652-14-28. J Int AIDS Soc. 2011. PMID: 21612619 Free PMC article. Review.

2

HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial.

Calmy A, Gayet-Ageron A, Montecucco F, Nguyen A, Mach F, Burger F, Ubolyam S, Carr A, Ruxungtham K, Hirschel B, Ananworanich J; STACCATO Study Group. Calmy A, et al. Among authors: hirschel b. AIDS. 2009 May 15;23(8):929-39. doi: 10.1097/qad.0b013e32832995fa. AIDS. 2009. PMID: 19425222 Clinical Trial.

3

A randomized crossover study to compare efavirenz and etravirine treatment.

Nguyen A, Calmy A, Delhumeau C, Mercier IK, Cavassini M, Fayet-Mello A, Elzi L, Genné D, Rauch A, Bernasconi E, Hirschel B; Swiss HIV Cohort Study. Nguyen A, et al. Among authors: hirschel b. AIDS. 2011 Jan 2;25(1):57-63. doi: 10.1097/QAD.0b013e32833f9f63. AIDS. 2011. PMID: 21076278 Clinical Trial.

4

Impact of highly active antiretroviral therapy on the molecular epidemiology of newly diagnosed HIV infections.

Ambrosioni J, Junier T, Delhumeau C, Calmy A, Hirschel B, Zdobnov E, Kaiser L, Yerly S; Swiss HIV Cohort Study. Ambrosioni J, et al. Among authors: hirschel b. AIDS. 2012 Oct 23;26(16):2079-86. doi: 10.1097/QAD.0b013e32835805b6. AIDS. 2012. PMID: 23052354

5

Glitazones in lipodystrophy syndrome induced by highly active antiretroviral therapy.

Calmy A, Hirschel B, Hans D, Karsegard VL, Meier CA. Calmy A, et al. Among authors: hirschel b. AIDS. 2003 Mar 28;17(5):770-2. doi: 10.1097/00002030-200303280-00022. AIDS. 2003. PMID: 12646807 Clinical Trial. No abstract available.

6

HIV viral load monitoring in resource-limited regions: optional or necessary?

Calmy A, Ford N, Hirschel B, Reynolds SJ, Lynen L, Goemaere E, Garcia de la Vega F, Perrin L, Rodriguez W. Calmy A, et al. Among authors: hirschel b. Clin Infect Dis. 2007 Jan 1;44(1):128-34. doi: 10.1086/510073. Epub 2006 Nov 28. Clin Infect Dis. 2007. PMID: 17143828

7

Initial treatment for HIV infection--an embarrassment of riches.

Hirschel B, Calmy A. Hirschel B, et al. N Engl J Med. 2008 May 15;358(20):2170-2. doi: 10.1056/NEJMe0803013. N Engl J Med. 2008. PMID: 18480210 No abstract available.

8

A new era of antiretroviral drug toxicity.

Calmy A, Hirschel B, Cooper DA, Carr A. Calmy A, et al. Among authors: hirschel b. Antivir Ther. 2009;14(2):165-79. doi: 10.1177/135965350901400203. Antivir Ther. 2009. PMID: 19430091 Review.

9

Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study.

Calmy A, Fux CA, Norris R, Vallier N, Delhumeau C, Samaras K, Hesse K, Hirschel B, Cooper DA, Carr A. Calmy A, et al. Among authors: hirschel b. J Infect Dis. 2009 Dec 1;200(11):1746-54. doi: 10.1086/644785. J Infect Dis. 2009. PMID: 19874178 Free article.

10

Safety and efficacy of once-daily nevirapine dosing: a multicohort study.

Calmy A, Vallier N, Nguyen A, Lange JM, Battegay M, de Wolf F, Reiss P, Lima VD, Hirschel B, Hogg RS, Yip B, Montaner JS, Wit FW; Swiss HIV Cohort study; HAART Observational Medical Evaluation and Research Cohort; Netherlands ATHENA Observational Cohort. Calmy A, et al. Among authors: hirschel b. Antivir Ther. 2009;14(7):931-8. doi: 10.3851/IMP1418. Antivir Ther. 2009. PMID: 19918097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

627 results

Search Page